case study

Biotechnology Process Control

About RCA
Regulatory Compliance Associates® Inc. (RCA) provides worldwide services to the pharmaceutical, biologic, sterile compounding, biotechnology, and medical device industries for resolution of compliance and regulatory challenges.

Please complete the form to access the case study.

*=Required

Biotechnology Process Control

Background

A Fortune 500 biotech company frequently had parts missing when assembling equipment for a campaign changeover. This led to expensive, last-minute part fabrication and concern about the potential for product manufacturing delays. These biotechnology process control delays caused tremendous stress for operations management about loss of revenue. Additionally, equipment setup was performed exclusively from Process and Instrumentation Diagrams, and relied on employees remembering setup details. A new process control strategy needed to be implemented for production. 

 

Challenge

Regulatory Compliance Associates® was contracted to identify and implement a biotechnology process control strategy that would solve the missing parts problem. During the initial investigation RCA discovered that the process was not documented in a manner the met GMP requirements. The solution needed not only to solve the missing parts issue, but also to create GMP documentation, demonstrating the process was in control.

 

Approach

After a thorough investigation, RCA created a process which included build lists, SOPs with color pictures embedded, and 3-D exploded diagrams for all setups. Additionally, all equipment parts were laser-etched with part numbers that corresponded to all biotechnology process control documentation. Sealed containers were used to store parts for a specific campaign. Extensive training was performed and continuous improvement metrics were established to ensure the program continued to be successful.

 

Result

Missing parts prior to setup has been eliminated. Documentation meets cGMP regulations, and is being used as a training tool, which reduces the risk of relying on tribal knowledge. Campaign changeover times have been reduced by a minimum of two days, and in some cases six days, resulting in a biotechnology process control cost reduction of $4 million per year.

 

To begin the Regulatory Compliance Associates® scoping process today, please enter your information in the blue form below and click the submit button at the bottom of the webpage. 

 

 

Background

A Fortune 500 biotech company frequently had parts missing when assembling equipment for a campaign changeover. This led to expensive, last-minute part fabrication and concern about the potential for product manufacturing delays. These biotechnology process control delays caused tremendous stress for operations management about loss of revenue. Additionally, equipment setup was performed exclusively from Process and Instrumentation Diagrams, and relied on employees remembering setup details. A new process control strategy needed to be implemented for production. 

 

Challenge

Regulatory Compliance Associates® was contracted to identify and implement a biotechnology process control strategy that would solve the missing parts problem. During the initial investigation RCA discovered that the process was not documented in a manner the met GMP requirements. The solution needed not only to solve the missing parts issue, but also to create GMP documentation, demonstrating the process was in control.

 

Approach

After a thorough investigation, RCA created a process which included build lists, SOPs with color pictures embedded, and 3-D exploded diagrams for all setups. Additionally, all equipment parts were laser-etched with part numbers that corresponded to all biotechnology process control documentation. Sealed containers were used to store parts for a specific campaign. Extensive training was performed and continuous improvement metrics were established to ensure the program continued to be successful.

 

Result

Missing parts prior to setup has been eliminated. Documentation meets cGMP regulations, and is being used as a training tool, which reduces the risk of relying on tribal knowledge. Campaign changeover times have been reduced by a minimum of two days, and in some cases six days, resulting in a biotechnology process control cost reduction of $4 million per year.

 

To begin the Regulatory Compliance Associates® scoping process today, please enter your information in the blue form below and click the submit button at the bottom of the webpage.